Additionally, Zhao et al. demonstrated that EFNA2 participates in the angiogenesis and epithelial-mesenchymal transformation of prostate cancer, further implying its tumorigenic actions [29]. This evidence concerns the gene EFNA2 and prostate carcinoma.